SelectQuote Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 6% year-over-year to $431 million, with Adjusted EBITDA up 18% to $45 million, driven by strong Senior and healthcare services performance. Fiscal 2026 guidance was reaffirmed, and operational efficiency gains, especially in SelectRx, are expected to drive future cash flow growth.
-
Revenue grew 12% year-over-year to $537M, with strong Senior and Healthcare Services performance and near-record margins. Fiscal 2026 guidance was reduced by $40M due to a carrier's marketing cut and PBM changes, but cash flow and profitability are expected to improve.
-
Fiscal Q1 revenue rose 13% to $329M, driven by healthcare and life insurance, while senior segment revenue fell due to SEP changes. PBM reimbursement headwinds impacted healthcare services, but long-term outlook and guidance remain positive.
Fiscal Year 2025
-
The meeting covered director elections, auditor ratification, and executive compensation, with all proposals approved by majority vote. No shareholder questions were raised, and risk factors were referenced in recent SEC filings.
-
Fiscal 2025 saw 16% revenue growth to $1.53B, led by Healthcare Services and SelectRx, with stable EBITDA margins and strong agent productivity. Fiscal 2026 guidance projects 11% revenue growth, $120–$150M EBITDA, and positive operating cash flow, supported by ongoing tech and efficiency gains.
-
Q3 revenue rose 8% to $408M, led by SelectRx's 41% membership growth and strong segment margins. Senior and life insurance segments delivered robust profitability, while new investments and industry changes are expected to impact near-term results.
-
Q2 revenue grew 19% year-over-year, driven by strong Medicare Advantage and SelectRx performance, with adjusted EBITDA up 30%. Capital structure improved via a $350M preferred equity raise and $100M securitization, reducing debt and interest costs. Fiscal 2025 guidance was raised for revenue, EBITDA, and net income.
-
Q1 revenue grew 26% to $292M, with strong SelectRx and agent productivity driving nearly $10M EBITDA improvement. Fiscal 2025 guidance was raised for both revenue and Adjusted EBITDA, supported by a $100M securitization and continued operational efficiencies.
Fiscal Year 2024
-
Fiscal 2024 saw revenue and EBITDA significantly exceed guidance, driven by strong Senior and Healthcare Services performance. 2025 growth will be tempered by capital constraints and commission changes, but long-term prospects remain robust, with a $100M securitization set to improve financial flexibility.